Iovance Biotherapeutics Inc (IOVA)
11.77
-0.26
(-2.16%)
USD |
NASDAQ |
Apr 30, 16:00
11.78
+0.01
(+0.08%)
After-Hours: 20:00
Iovance Biotherapeutics Cash from Operations (TTM): -361.82M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -361.82M |
| September 30, 2023 | -355.52M |
| June 30, 2023 | -335.09M |
| March 31, 2023 | -318.77M |
| December 31, 2022 | -292.76M |
| September 30, 2022 | -268.94M |
| June 30, 2022 | -262.98M |
| March 31, 2022 | -239.35M |
| December 31, 2021 | -227.94M |
| September 30, 2021 | -236.78M |
| June 30, 2021 | -219.61M |
| March 31, 2021 | -202.23M |
| December 31, 2020 | -205.13M |
| September 30, 2020 | -196.26M |
| June 30, 2020 | -197.93M |
| March 31, 2020 | -195.09M |
| December 31, 2019 | -158.89M |
| September 30, 2019 | -136.62M |
| June 30, 2019 | -122.36M |
| March 31, 2019 | -112.49M |
| December 31, 2018 | -101.25M |
| September 30, 2018 | -90.66M |
| June 30, 2018 | -84.18M |
| March 31, 2018 | -77.76M |
| December 31, 2017 | -78.71M |
| Date | Value |
|---|---|
| September 30, 2017 | -69.90M |
| June 30, 2017 | -60.67M |
| March 31, 2017 | -46.92M |
| December 31, 2016 | -32.67M |
| September 30, 2016 | -27.09M |
| June 30, 2016 | -18.72M |
| March 31, 2016 | -19.47M |
| December 31, 2015 | -18.38M |
| September 30, 2015 | -15.12M |
| June 30, 2015 | -13.00M |
| March 31, 2015 | -9.825M |
| December 31, 2014 | -8.633M |
| September 30, 2014 | -7.57M |
| June 30, 2014 | -6.269M |
| March 31, 2014 | -5.628M |
| December 31, 2013 | -3.661M |
| September 30, 2013 | -1.409M |
| June 30, 2013 | -1.263M |
| March 31, 2013 | -1.781M |
| December 31, 2012 | -2.242M |
| September 30, 2012 | -4.951M |
| June 30, 2012 | -6.320M |
| March 31, 2012 | -6.385M |
| December 31, 2011 | -6.189M |
| September 30, 2011 | -3.849M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-361.82M
Minimum
Dec 2023
-122.36M
Maximum
Jun 2019
-238.64M
Average
-227.94M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
| QuidelOrtho Corp | 280.20M |
| Perspective Therapeutics Inc | -36.91M |
| Electromed Inc | 4.872M |
| Xtant Medical Holdings Inc | -9.515M |
| Asensus Surgical Inc | -63.63M |